Increased endothelial microparticles and oxidative stress at extreme altitude

European Journal of Applied Physiology

Volumn 116, Issue 4, 2016, Pages 739-748

  Pichler Hefti, Jacqueline ^a   Leichtle, Alexander ^a   Stutz, Monika ^a   Hefti, Urs ^b   Geiser, Thomas ^a   Huber, Andreas R ^c   Merz, Tobias M ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Swiss Sportsclinic   (Switzerland)

^c CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

Endothelial dysfunction; Extreme altitude; Hypoxia; Microparticles; Oxidative stress

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; BIOLOGICAL MARKER; PROSTAGLANDIN; VITAMIN;

ADULT; ALTITUDE; APOPTOSIS; BLOOD; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPOXIA; MALE; MEMBRANE MICROPARTICLE; MIDDLE AGED; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; VASCULAR ENDOTHELIUM;

ACETYLCYSTEINE; ADULT; ALTITUDE; ANTIOXIDANTS; APOPTOSIS; BIOMARKERS; CELL-DERIVED MICROPARTICLES; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPOXIA; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROSTAGLANDINS; VITAMINS;

EID: 84955563911     PISSN: 14396319     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00421-015-3309-3     Document Type: Article

References (82)

1. Akinnusi ME, El Solh AA (2009) Circulating endothelial microparticle levels and hemodynamic severity of pulmonary hypertension: is there a role for sleep apnea? Am J Respir Crit Care Med 179(4):328
2. Amabile N, Heiss C, Real WM, Minasi P, McGlothlin D, Rame EJ, Grossman W, De Marco T, Yeghiazarians Y (2008) Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension. Am J Respir Crit Care Med 177(11):1268–1275. doi:10.1164/rccm.200710-1458OC
3. Amabile N, Heiss C, Chang V, Angeli FS, Damon L, Rame EJ, McGlothlin D, Grossman W, De Marco T, Yeghiazarians Y (2009) Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients. J Heart Lung Transplant 28(10):1081–1086. doi:10.1016/j.healun.2009.06.005
4. Angelini DJ, Hyun SW, Grigoryev DN, Garg P, Gong P, Singh IS, Passaniti A, Hasday JD, Goldblum SE (2006) TNF-alpha increases tyrosine phosphorylation of vascular endothelial cadherin and opens the paracellular pathway through fyn activation in human lung endothelia. Am J Physiol Lung Cell Mol Physiol 291(6):L1232–L1245. doi:10.1152/ajplung.00109.2006
5. Ayers L, Stoewhas AC, Ferry B, Latshang TD, Lo Cascio CM, Sadler R, Stadelmann K, Tesler N, Huber R, Achermann P, Bloch KE, Kohler M (2014) Circulating levels of cell-derived microparticles are reduced by mild hypobaric hypoxia: data from a randomised controlled trial. Eur J Appl Physiol 114(5):1067–1073. doi:10.1007/s00421-014-2837-6
6. Bailey DM, Davies B (2001) Acute mountain sickness; prophylactic benefits of antioxidant vitamin supplementation at high altitude. High Alt Med Biol 2(1):21–29. doi:10.1089/152702901750067882
7. Bailey DM, Roukens R, Knauth M, Kallenberg K, Christ S, Mohr A, Genius J, Storch-Hagenlocher B, Meisel F, McEneny J, Young IS, Steiner T, Hess K, Bartsch P (2006) Free radical-mediated damage to barrier function is not associated with altered brain morphology in high-altitude headache. J Cereb Blood Flow Metab 26(1):99–111. doi:10.1038/sj.jcbfm.9600169
8. Bailey DM, Evans KA, James PE, McEneny J, Young IS, Fall L, Gutowski M, Kewley E, McCord JM, Moller K, Ainslie PN (2009) Altered free radical metabolism in acute mountain sickness: implications for dynamic cerebral autoregulation and blood-brain barrier function. J Physiol 587(Pt 1):73–85. doi:10.1113/jphysiol.2008.159855
9. Bailey DM, Dehnert C, Luks AM, Menold E, Castell C, Schendler G, Faoro V, Gutowski M, Evans KA, Taudorf S, James PE, McEneny J, Young IS, Swenson ER, Mairbaurl H, Bartsch P, Berger MM (2010) High-altitude pulmonary hypertension is associated with a free radical-mediated reduction in pulmonary nitric oxide bioavailability. J Physiol 588(Pt 23):4837–4847. doi:10.1113/jphysiol.2010.194704
10. Baillie JK, Thompson AA, Irving JB, Bates MG, Sutherland AI, Macnee W, Maxwell SR, Webb DJ (2009) Oral antioxidant supplementation does not prevent acute mountain sickness: double blind, randomized placebo-controlled trial. QJM Mon J Assoc Phys 102(5):341–348. doi:10.1093/qjmed/hcp026
11. Bakouboula B, Morel O, Faure A, Zobairi F, Jesel L, Trinh A, Zupan M, Canuet M, Grunebaum L, Brunette A, Desprez D, Chabot F, Weitzenblum E, Freyssinet JM, Chaouat A, Toti F (2008) Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. Am J Respir Crit Care Med 177(5):536–543. doi:10.1164/rccm.200706-840OC
12. Berger MM, Hesse C, Dehnert C, Siedler H, Kleinbongard P, Bardenheuer HJ, Kelm M, Bartsch P, Haefeli WE (2005) Hypoxia impairs systemic endothelial function in individuals prone to high-altitude pulmonary edema. Am J Respir Crit Care Med 172(6):763–767. doi:10.1164/rccm.200504-654OC
13. Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C (2012) Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 3:CD007176. doi:10.1002/14651858.CD007176.pub2
14. Boaz M, Smetana S, Weinstein T, Matas Z, Gafter U, Iaina A, Knecht A, Weissgarten Y, Brunner D, Fainaru M, Green MS (2000) Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet 356(9237):1213–1218
15. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, Mallat Z (2001) Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 104(22):2649–2652
16. Boulanger CM, Amabile N, Guerin AP, Pannier B, Leroyer AS, Mallat CN, Tedgui A, London GM (2007) In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease. Hypertension 49(4):902–908. doi:10.1161/01.HYP.0000259667.22309.df
17. Budhiraja R, Tuder RM, Hassoun PM (2004) Endothelial dysfunction in pulmonary hypertension. Circulation 109(2):159–165. doi:10.1161/01.CIR.0000102381.57477.50
18. Bull TM, Golpon H, Hebbel RP, Solovey A, Cool CD, Tuder RM, Geraci MW, Voelkel NF (2003) Circulating endothelial cells in pulmonary hypertension. Thromb Haemost 90(4):698–703. doi:10.1267/THRO03040698
19. Burhop KE, Selig WM, Malik AB (1988) Monohydroxyeicosatetraenoic acids (5-HETE and 15-HETE) induce pulmonary vasoconstriction and edema. Circ Res 62(4):687–698
20. Chandel NS, Maltepe E, Goldwasser E, Mathieu CE, Simon MC, Schumacker PT (1998) Mitochondrial reactive oxygen species trigger hypoxia-induced transcription. Proc Natl Acad Sci USA 95(20):11715–11720
21. Chandler WL, Yeung W, Tait JF (2011) A new microparticle size calibration standard for use in measuring smaller microparticles using a new flow cytometer. J Thromb Haemost 9(6):1216–1224. doi:10.1111/j.1538-7836.2011.04283.x
22. Chao WH, Askew EW, Roberts DE, Wood SM, Perkins JB (1999) Oxidative stress in humans during work at moderate altitude. J Nutr 129(11):2009–2012
23. Chaumais MC, Ranchoux B, Montani D, Dorfmuller P, Tu L, Lecerf F, Raymond N, Guignabert C, Price L, Simonneau G, Cohen-Kaminsky S, Humbert M, Perros F (2014) N-acetylcysteine improves established monocrotaline-induced pulmonary hypertension in rats. Respir Res 15:65. doi:10.1186/1465-9921-15-65
24. Chichger H, Duong H, Braza J, Harrington EO (2014) p18, a novel adaptor protein, regulates pulmonary endothelial barrier function via enhanced endocytic recycling of VE-cadherin. FASEB J Off Publ Fed Am Soc Exp Biol. doi:10.1096/fj.14-257212
25. Connolly MJ, Aaronson PI (2010) Cell redox state and hypoxic pulmonary vasoconstriction: recent evidence and possible mechanisms. Respir Physiol Neurobiol 174(3):165–174. doi:10.1016/j.resp.2010.08.016
26. Corada M, Liao F, Lindgren M, Lampugnani MG, Breviario F, Frank R, Muller WA, Hicklin DJ, Bohlen P, Dejana E (2001) Monoclonal antibodies directed to different regions of vascular endothelial cadherin extracellular domain affect adhesion and clustering of the protein and modulate endothelial permeability. Blood 97(6):1679–1684
27. Deanfield JE, Halcox JP, Rabelink TJ (2007) Endothelial function and dysfunction: testing and clinical relevance. Circulation 115(10):1285–1295. doi:10.1161/circulationaha.106.652859
28. Delannoy E, Courtois A, Freund-Michel V, Leblais V, Marthan R, Muller B (2010) Hypoxia-induced hyperreactivity of pulmonary arteries: role of cyclooxygenase-2, isoprostanes, and thromboxane receptors. Cardiovasc Res 85(3):582–592. doi:10.1093/cvr/cvp292
29. Delanty N, Reilly M, Pratico D, FitzGerald DJ, Lawson JA, FitzGerald GA (1996) 8-Epi PGF2 alpha: specific analysis of an isoeicosanoid as an index of oxidant stress in vivo. Br J Clin Pharmacol 42(1):15–19
30. Dosek A, Ohno H, Acs Z, Taylor AW, Radak Z (2007) High altitude and oxidative stress. Respir Physiol Neurobiol 158(2–3):128–131. doi:10.1016/j.resp.2007.03.013
31. Fike CD, Kaplowitz MR, Pfister SL (2003) Arachidonic acid metabolites and an early stage of pulmonary hypertension in chronically hypoxic newborn pigs. Am J Physiol Lung Cell Mol Physiol 284(2):L316–L323. doi:10.1152/ajplung.00228.2002
32. Herren B, Levkau B, Raines EW, Ross R (1998) Cleavage of beta-catenin and plakoglobin and shedding of VE-cadherin during endothelial apoptosis: evidence for a role for caspases and metalloproteinases. Mol Biol Cell 9(6):1589–1601
33. Hjuler Nielsen M, Irvine H, Vedel S, Raungaard B, Beck-Nielsen H, Handberg A (2015) Elevated atherosclerosis-related gene expression, monocyte activation and microparticle-release are related to increased lipoprotein-associated oxidative stress in familial hypercholesterolemia. PLoS One 10(4):e0121516. doi:10.1371/journal.pone.0121516
34. Hooper DC, Scott GS, Zborek A, Mikheeva T, Kean RB, Koprowski H, Spitsin SV (2000) Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J Off Publ Fed Am Soc Exp Biol 14(5):691–698
35. Horigome H, Hiramatsu Y, Shigeta O, Nagasawa T, Matsui A (2002) Overproduction of platelet microparticles in cyanotic congenital heart disease with polycythemia. J Am Coll Cardiol 39(6):1072–1077
36. Hoshikawa Y, Ono S, Suzuki S, Tanita T, Chida M, Song C, Noda M, Tabata T, Voelkel NF, Fujimura S (2001) Generation of oxidative stress contributes to the development of pulmonary hypertension induced by hypoxia. J Appl Physiol (1985) 90(4):1299–1306
37. Hoyos B, Acin-Perez R, Fischman DA, Manfredi G, Hammerling U (2012) Hiding in plain sight: uncovering a new function of vitamin A in redox signaling. Biochim Biophys Acta 1821 1:241–247. doi:10.1016/j.bbalip.2011.06.014
38. Ihlemann N, Rask-Madsen C, Perner A, Dominguez H, Hermann T, Kober L, Torp-Pedersen C (2003) Tetrahydrobiopterin restores endothelial dysfunction induced by an oral glucose challenge in healthy subjects. Am J Physiol Heart Circ Physiol 285(2):H875–H882. doi:10.1152/ajpheart.00008.2003
39. Jimenez JJ, Jy W, Mauro LM, Soderland C, Horstman LL, Ahn YS (2003) Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 109(4):175–180
40. Kuiper HC, Bruno RS, Traber MG, Stevens JF (2011) Vitamin C supplementation lowers urinary levels of 4-hydroperoxy-2-nonenal metabolites in humans. Free Radic Biol Med 50(7):848–853. doi:10.1016/j.freeradbiomed.2011.01.004
41. Lewis NC, Bailey DM, Dumanoir GR, Messinger L, Lucas SJ, Cotter JD, Donnelly J, McEneny J, Young IS, Stembridge M, Burgess KR, Basnet AS, Ainslie PN (2014) Conduit artery structure and function in lowlanders and native highlanders: relationships with oxidative stress and role of sympathoexcitation. J Physiol 592(Pt 5):1009–1024. doi:10.1113/jphysiol.2013.268615
42. Lichtenauer M, Goebel B, Fritzenwanger M, Forster M, Betge S, Lauten A, Figulla HR, Jung C (2014) Simulated temporary hypoxia triggers the release of CD31+/Annexin + endothelial microparticles: a prospective pilot study in humans. Clin Hemorheol Microcirc. doi:10.3233/CH-141908
43. Lynch SF, Ludlam CA (2007) Plasma microparticles and vascular disorders. Br J Haematol 137(1):36–48. doi:10.1111/j.1365-2141.2007.06514.x
44. Maggiorini M, Melot C, Pierre S, Pfeiffer F, Greve I, Sartori C, Lepori M, Hauser M, Scherrer U, Naeije R (2001) High-altitude pulmonary edema is initially caused by an increase in capillary pressure. Circulation 103(16):2078–2083
45. Marcos-Ramiro B, Oliva Nacarino P, Serrano-Pertierra E, Blanco-Gelaz MA, Weksler BB, Romero IA, Couraud PO, Tunon A, Lopez-Larrea C, Millan J, Cernuda-Morollon E (2014) Microparticles in multiple sclerosis and clinically isolated syndrome: effect on endothelial barrier function. BMC Neurosci 15:110. doi:10.1186/1471-2202-15-110
46. Mastronardi ML, Mostefai HA, Meziani F, Martinez MC, Asfar P, Andriantsitohaina R (2011) Circulating microparticles from septic shock patients exert differential tissue expression of enzymes related to inflammation and oxidative stress. Crit Care Med 39(7):1739–1748. doi:10.1097/CCM.0b013e3182190b4b
47. Milne GL, Yin H, Brooks JD, Sanchez S, Jackson Roberts L 2nd, Morrow JD (2007) Quantification of F2-isoprostanes in biological fluids and tissues as a measure of oxidant stress. Methods Enzymol 433:113–126. doi:10.1016/S0076-6879(07)33006-1
48. Montezano AC, Dulak-Lis M, Tsiropoulou S, Harvey A, Briones AM, Touyz RM (2015) Oxidative stress and human hypertension: vascular mechanisms, biomarkers, and novel therapies. Can J Cardiol 31(5):631–641. doi:10.1016/j.cjca.2015.02.008
49. Montoro-Garcia S, Shantsila E, Marin F, Blann A, Lip GY (2011) Circulating microparticles: new insights into the biochemical basis of microparticle release and activity. Basic Res Cardiol. doi:10.1007/s00395-011-0198-4
50. Montuschi P, Barnes PJ, Roberts LJ 2nd (2004) Isoprostanes: markers and mediators of oxidative stress. FASEB J Off Publ Fed Am Soc Exp Biol 18(15):1791–1800. doi:10.1096/fj.04-2330rev
51. 2-production in the pig coronary artery. Circulation 96(10):3593–3601
52. Palace VP, Hill MF, Khaper N, Singal PK (1999) Metabolism of vitamin A in the heart increases after a myocardial infarction. Free Radic Biol Med 26(11–12):1501–1507
53. Pichler Hefti J, Risch L, Hefti U, Scharrer I, Risch G, Merz TM, Turk A, Bosch MM, Barthelmess D, Schoch O, Maggiorini M, Huber AR (2010) Changes of coagulation parameters during high altitude expedition. Swiss Med Wkly 140(7–8):111–117
54. Pichler Hefti J, Sonntag D, Hefti U, Risch L, Schoch OD, Turk AJ, Hess T, Bloch KE, Maggiorini M, Merz TM, Weinberger KM, Huber AR (2013) Oxidative stress in hypobaric hypoxia and influence on vessel-tone modifying mediators. High Alt Med Biol 14(3):273–279. doi:10.1089/ham.2012.1110
55. Pratico D, Tangirala RK, Rader DJ, Rokach J, FitzGerald GA (1998) Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in ApoE-deficient mice. Nat Med 4(10):1189–1192. doi:10.1038/2685
56. Roach RC, Bartsch P, Hackett PH, Oelz O (1993) Hypoxia and molecular medicine. In: The Lake Louise acute mountain sickness scoring system. Suton JR, Coates G, Houston Ch, Burlington
57. Schmidt MC, Askew EW, Roberts DE, Prior RL, Ensign WY Jr, Hesslink RE Jr (2002) Oxidative stress in humans training in a cold, moderate altitude environment and their response to a phytochemical antioxidant supplement. Wilderness Environ Med 13(2):94–105
58. Schofield CJ, Ratcliffe PJ (2004) Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 5(5):343–354. doi:10.1038/nrm1366
59. Schulz B, Pruessmeyer J, Maretzky T, Ludwig A, Blobel CP, Saftig P, Reiss K (2008) ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin. Circ Res 102(10):1192–1201. doi:10.1161/CIRCRESAHA.107.169805
60. Sidibe A, Imhof BA (2014) VE-cadherin phosphorylation decides: vascular permeability or diapedesis. Nat Immunol 15(3):215–217. doi:10.1038/ni.2825
61. Stephens NG, Parsons A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ (1996) Randomised controlled trial of vitamin E in patients with coronary disease: cambridge Heart Antioxidant Study (CHAOS). Lancet 347(9004):781–786
62. Thiagarajan P, Tait JF (1991) Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J Biol Chem 266(36):24302–24307
63. Toth B, Nikolajek K, Rank A, Nieuwland R, Lohse P, Pihusch V, Friese K, Thaler CJ (2007) Gender-specific and menstrual cycle dependent differences in circulating microparticles. Platelets 18(7):515–521. doi:10.1080/09537100701525843
64. Traber MG, Stevens JF (2011) Vitamins C and E: beneficial effects from a mechanistic perspective. Free Radic Biol Med 51(5):1000–1013. doi:10.1016/j.freeradbiomed.2011.05.017
65. Tsimerman G, Roguin A, Bachar A, Melamed E, Brenner B, Aharon A (2011) Involvement of microparticles in diabetic vascular complications. Thromb Haemost. doi:10.1160/TH10-11-0712
66. Tual-Chalot S, Guibert C, Muller B, Savineau JP, Andriantsitohaina R, Martinez MC (2010) Circulating microparticles from pulmonary hypertensive rats induce endothelial dysfunction. Am J Respir Crit Care Med 182(2):261–268. doi:10.1164/rccm.200909-1347OC
67. Tushuizen ME, Nieuwland R, Scheffer PG, Sturk A, Heine RJ, Diamant M (2006) Two consecutive high-fat meals affect endothelial-dependent vasodilation, oxidative stress and cellular microparticles in healthy men. J Thromb Haemost 4(5):1003–1010. doi:10.1111/j.1538-7836.2006.01914.x
68. Tzima E, Irani-Tehrani M, Kiosses WB, Dejana E, Schultz DA, Engelhardt B, Cao G, DeLisser H, Schwartz MA (2005) A mechanosensory complex that mediates the endothelial cell response to fluid shear stress. Nature 437(7057):426–431. doi:10.1038/nature03952
69. van der Pol E, van Gemert MJ, Sturk A, Nieuwland R, van Leeuwen TG (2012) Single vs swarm detection of microparticles and exosomes by flow cytometry. J Thromb Haemost JTH 10(5):919–930. doi:10.1111/j.1538-7836.2012.04683.x
70. VanWijk MJ, VanBavel E, Sturk A, Nieuwland R (2003) Microparticles in cardiovascular diseases. Cardiovasc Res 59(2):277–287
71. Vasquez-Vivar J, Hogg N, Martasek P, Karoui H, Pritchard KA Jr, Kalyanaraman B (1999) Tetrahydrobiopterin-dependent inhibition of superoxide generation from neuronal nitric oxide synthase. J Biol Chem 274(38):26736–26742
72. Vion AC, Ramkhelawon B, Loyer X, Chironi G, Devue C, Loirand G, Tedgui A, Lehoux S, Boulanger CM (2013) Shear stress regulates endothelial microparticle release. Circ Res 112(10):1323–1333. doi:10.1161/CIRCRESAHA.112.300818
73. Wallez Y, Huber P (2008) Endothelial adherens and tight junctions in vascular homeostasis, inflammation and angiogenesis. Biochim Biophys Acta 1778(3):794–809. doi:10.1016/j.bbamem.2007.09.003
74. Werner N, Wassmann S, Ahlers P, Kosiol S, Nickenig G (2006) Circulating CD31+/annexin V+ apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 26(1):112–116. doi:10.1161/01.ATV.0000191634.13057.15
75. Westerterp-Plantenga MS, Westerterp KR, Rubbens M, Verwegen CR, Richelet JP, Gardette B (1999) Appetite at “high altitude” [Operation Everest III (Comex-’97)]: a simulated ascent of Mount Everest. J Appl Physiol (1985) 87(1):391–399
76. Wingler K, Wunsch S, Kreutz R, Rothermund L, Paul M, Schmidt HH (2001) Upregulation of the vascular NAD(P)H-oxidase isoforms Nox1 and Nox4 by the renin-angiotensin system in vitro and in vivo. Free Radic Biol Med 31(11):1456–1464
77. Wohlfart P, Xu H, Endlich A, Habermeier A, Closs EI, Hubschle T, Mang C, Strobel H, Suzuki T, Kleinert H, Forstermann U, Ruetten H, Li H (2008) Antiatherosclerotic effects of small-molecular-weight compounds enhancing endothelial nitric-oxide synthase (eNOS) expression and preventing eNOS uncoupling. J Pharmacol Exp Ther 325(2):370–379. doi:10.1124/jpet.107.128009
78. Wray DW, Nishiyama SK, Harris RA, Zhao J, McDaniel J, Fjeldstad AS, Witman MA, Ives SJ, Barrett-O’Keefe Z, Richardson RS (2012) Acute reversal of endothelial dysfunction in the elderly after antioxidant consumption. Hypertension 59(4):818–824. doi:10.1161/HYPERTENSIONAHA.111.189456
79. Yoshida Y, Niki E (2006) Bio-markers of lipid peroxidation in vivo: hydroxyoctadecadienoic acid and hydroxycholesterol. BioFactors 27(1–4):195–202
80. Yu X, Li T, Liu X, Yu H, Hao Z, Chen Y, Zhang C, Liu Y, Li Q, Mao M, Zhu D (2015) Modulation of pulmonary vascular remodeling in hypoxia: role of 15-LOX-2/15-HETE-MAPKs pathway. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol 35(6):2079–2097. doi:10.1159/000374015
81. Yuan SY (2002) Protein kinase signaling in the modulation of microvascular permeability. Vascul Pharmacol 39(4–5):213–223
82. Zwaal RF, Schroit AJ (1997) Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89(4):1121–1132